Clinical Trial Update: Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing FYU-981 to benzbromarone in hyperuricemia with or without gout has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia with or Without Gout

Drugs mentioned

• FYU-981
• benzbromarone (benzbromarone)

Snippet

Sponsor: Fuji Yakuhin Co., Ltd. | Conditions: Hyperuricemia With or Without Gout | Phase 3 | Status: COMPLETED